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Abstract Glycogen synthase kinase (GSK)-3β, which is
abundantly expressed in the central nervous system, reg-
ulates various cellular processes including gene expres-
sion, cell proliferation, and differentiation. However, in-
volvement of GSK-3β in cerebral ischemia-induced en-
dogenous neurogenesis is not yet fully understood.
Appropriate strategies to prevent ischemic cell damage
and subsequent severe sequelae are needed. The purpose
of the present study was to determine the relationship
between pathophysiological alteration of the GSK-3β sig-
naling pathway and cerebral ischemia-induced endoge-
nous neurogenesis in rats. Severe cerebral ischemia was
produced by the injection of 700 microspheres into the
right internal carotid artery of rats. We demonstrated that
phosphorylation of GSK-3β at its Ser9 and that of Akt
was significantly enhanced on day 7 after the cerebral
ischemia, as was the number of NeuroD-positive cells.
Treatment with a phosphatidylinositol 3-kinase (PI3-K)
inhibitor decreased the cerebral ischemia-induced phos-
phorylation of Akt and that of GSK-3β at its Ser9. In
addition, as the protein levels of insulin-like growth
factor-1 (IGF-1) and brain-derived neurotrophic factor
(BDNF) were decreased, they might not have been essen-
tial for activation of the PI3-K/Akt/GSK-3β pathway after
severe cerebral ischemia. Although it remains to be
determined what factors activate this pathway, our results
suggest that PI3K/Akt-dependent GSK-3β signaling and
subsequent expression of NeuroD were involved in the
neurogenesis elicited by cerebral ischemia.
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Introduction
Glycogen synthase kinase-3 (GSK-3), a serine/threonine
(Ser/Thr) kinase, was identified some time ago as an
enzyme that phosphorylates glycogen synthase to render
it inactive [1]. There are two isoforms of it, i.e., α and
β. GSK-3β is abundantly expressed in the mammalian
central nervous system and regulates various cellular
processes including gene expression, cell proliferation,
and differentiation. β-Catenin is a signaling molecule
that is phosphorylated by GSK-3β, resulting in its deg-
radation by the ubiquitin-proteasome system. Thus,
inactivated GSK-3β, which is phosphorylated at its
Ser9, inhibits this proteasomal degradation of β-catenin.
As a result, β-catenin accumulates in the cytosol and is
translocated into the nucleus, where it contributes to
gene expression related to cell proliferation and differ-
entiation [2, 3]. Therefore, β-catenin has been implicat-
ed in the maintenance of the stem cell pool [4], neuro-
nal differentiation [5], and the development of the cen-
tral nervous system [6]. NeuroD, which is a proneural
basic helix-loop-helix (bHLH) transcription factor, pro-
motes premature cell cycle exit and differentiation into
neural progenitor cells, indicating a differentiation factor
[7, 8]. Its expression is regulated by β-catenin [9].
Some studies have indicated that NeuroD is also
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involved in not only embryonic neurogenesis but also in
postnatal neurogenesis [10, 11]. Furthermore, environ-
mental signals regulate adult neurogenesis, at least in
part, through the activation of NeuroD [12, 13].
It has been shown that neurogenesis occurs in two re-
stricted areas of the brain, i.e., the subventricular zone of
the lateral ventricles and subgranular zone (SGZ) of hip-
pocampal den ta te gyrus , th roughout l i f e [14] .
Furthermore, the existence of additional stem cell niches
for neurogenesis was demonstrated, such as the substantia
nigra, circumventricular organs located along the ventric-
ular midline, and the walls of the third and fourth ventri-
cles [15–17]. The process of neurogenesis is closely relat-
ed to neurological functions involving spatial learning,
memory, and behavioral response [18] and is regulated
by various factors such as age, drugs, disease, and the
environment. Indeed, anti-depressants improve depression
symptoms, and there is a correlation between their use
and restoration of impaired neurogenesis in the hippocam-
pus [19]. Cerebral ischemia also enhances neurogenesis
[20–22]. In addition, it has been implied that neurons
newly generated after cerebral ischemia migrate to the
injured area [23, 24] and replace the injured or dead neu-
rons [20]. Some of these cells might be integrated into the
existing neural network or form new ones. Therefore, ac-
celeration of endogenous neurogenesis in the brain has
been expected as new therapeutic approach for cerebral
ischemia. However, it has been shown that the majority
of newly generated endogenous neurons fail to survive.
Rather, neural stem/progenitor cells without proliferation
activity secrete autocrine and/or paracrine factors to main-
tain the multipotency in the central nervous system [25].
Furthermore, neural stem cells, when transplanted into
lesion sites in an injured spinal cord, have the ability to
increase the expression of neurotrophic factors [26, 27].
In this sense, we demonstrated previously that the injec-
tion of neural progenitor cells (NPCs), which were isolat-
ed by using the neurosphere method, results in improve-
ment of spatial learning dysfunction and post-stroke de-
pression [28, 29]. However, the pathophysiological alter-
ations leading to cerebral ischemia-induced endogenous
neurogenesis are not fully understood. Therefore, it is
important to investigate the pathophysiological environ-
ment underlying cerebral ischemia-induced neurogenesis
for appropriate therapies for stroke. Elucidating the reg-
ulation of endogenous neurogenesis in cerebral ischemia
may lead to a further understanding of the pathophysi-
ology of stroke and the development of new therapeutic
targets. The aim of this study was to determine the
relationship between pathophysiological alteration of
the GSK-3β signaling pathway and the initial stages




Male Wistar rats weighing 220–250 g (Charles River Japan
Inc., Tsukuba, Japan) were used. The rats were maintained at
23 ± 1 °C in a roomwith a constant humidity of 55 ± 5% and a
light cycle of 12-h light/12-h darkness. The rats had free ac-
cess to food and water according to the National Institute of
Health Guide for the Care and Use of Laboratory Animals and
the Guidance for Experimental Animal Care issued by the
Prime Minister’s Office of Japan. The study was approved
by the Committee of Animal Care and Welfare of Tokyo
University of Pharmacy and Life Sciences. Microsphere-
induced cerebral embolism (ME) was performed by the meth-
od described previously [30]. Anesthesia was induced with
4% isoflurane and maintained with 2.5% isoflurane. The right
external carotid and pterygopalatine arteries were temporarily
occluded with strings. Immediately thereafter, a needle con-
nected to a polyethylene catheter (TORAY Feeding Tube,
Chiba, Japan) was inserted into the right common carotid ar-
tery. Next, 700 microspheres (45.0 μm in diameter;
Polysciences Inc., Warrington, PA, USA), suspended in 20%
dextran solution (150μl), were injected over a 20-s period into
the right internal carotid artery through the cannula. After the
injection, the needle was removed, and the puncture wound
was then repaired with surgical glue. Sham-operated rats re-
ceived the same volume of vehicle without microspheres.
Non-operated rats were used as naïve control rats in the pres-
ent study. As described in earlier reports [31, 32], scattered
necrotic areas, variable in size and shape, were seen mainly in
the parietotemporal cortex, corpus callosum, hippocampus,
thalamus, and lenticular nucleus of the ipsilateral hemisphere
after microsphere embolism. In the present study, 41 ME rats
were prepared for experiments. Among these rats, 6 of them
(14.6%) died within 3 days after the operation. Twenty-five
sham-operated rats survived throughout the experiments.
Wortmannin (Sigma-Aldrich, Inc. MO, USA), which is a
potent and selective inhibitor of phosphatidylinositol 3-kinase
(PI3-K; IC50 = 2 nM; [33]), was dissolved in dimethyl sulf-
oxide and injected intravenously, as previously reported [34,
35], on days 5 and 6 afterME. For tissue sampling forWestern
blotting and histochemical analysis, wortmannin-untreated
and wortmannin-treated cerebral ischemic rats were sacrificed
on day 7 after surgery. The dose used in the present study was
based on the data obtained in our preliminary study: the effect
of treatment with 30 μg/kgwortmannin on phosphorylation of
Akt was more stable than that with 15 or 100 μg/kg.
Western Immunoblotting
Rats were sacrificed by decapitation on days 1, 3, 7, and
14 day after surgery for cerebral ischemia- or sham-operated
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rats (n = 5 each). To determine the effects of wortmannin on
the phosphorylation of Akt, wortmannin-treated cerebral is-
chemic rats were sacrificed by decapitation on day 7 after
surgery (n = 5). The ipsilateral hemisphere was homogenized
in ice-cold buffer containing 320 mM sucrose, protease inhib-
itors, and phosphatase inhibitor cocktail (Roche Diagnostics
Co.) at 4 °C. The homogenate was centrifuged at 1000g for
10 min at 4 °C. The supernatant was then collected and sub-
sequently centrifuged at 12,000g for 20 min. After this second
centrifugation, the supernatant was collected and centrifuged
at 100,000g in a TLA120.2 rotor (Beckman Coulter) for
60 min at 4 °C. After centrifugation, the supernatant was col-
lected and used as the cytosolic fraction. Western blotting
using total homogenate and cytosolic fraction was performed
according to standard protocols. The following primary anti-
bodies were used: rabbit monoclonal anti-phospho-GSK-3β
(Ser 9; Cat. No. 5558, Cell Signaling Technology Inc.,
Danvers, MA, USA), mouse monoclonal anti-phospho-
GSK-3α/β (Tyr 279/Tyr 216; Cat. No. 05-413, Upstate
Biotechnology Inc.), rabbit monoclonal anti-GSK-3β (Cell
Signaling), rabbit monoclonal anti-phospho-Akt (Cell
Signaling), rabbit monoclonal anti-Akt (Cat. No. 4691, Cell
Signaling), rabbit polyclonal anti-phospho-β-catenin (Cat.
No. 9561, Cell Signaling), mouse monoclonal anti-β-catenin
(Cat. No. ab6301; Abcam, Minneapolis, MN, USA), goat
polyclonal anti-NeuroD (Cat. No. SC-1084, Santa Cruz),
mouse monoclonal anti-GAPDH (Cat. No. MAB374,
Millipore, Massachusetts, USA), rabbit polyclonal anti-
brain-derived neurotrophic factor (BDNF; Cat. No. SC-546,
Santa Cruz), rabbit polyclonal anti- insulin-like growth factor-
1 (IGF-1; Cat. No. SC-9013, Santa Cruz), and mouse mono-
clonal anti-β-actin (Cat. No. A1978, Sigma-Aldrich) anti-
body. Subsequently, the protein blots were washed and incu-
bated with the appropriate secondary antibodies. Bound anti-
bodies were detected by the enhanced chemiluminescence
method (Amersham Biosciences Inc., Piscataway, NJ, USA).
Quantification was performed by using computerized densi-
tometry (LuminographII, ATTO Co., Tokyo, Japan) and an
image analyzer (CS Analyzer, ATTO Co., Tokyo, Japan).
Immunohistochemistry
On day 7 after surgery, wortmannin-untreated (n = 5) and
wortmannin-treated (n = 5) cerebral ischemic rats were per-
fused via the heart with 4% paraformaldehyde in 0.1 M phos-
phate buffer. The brains were quickly removed and immersed
in 30% sucrose in 0.1 M phosphate buffer. They were then cut
into 5-mm-thick coronal slabs, which were subsequently em-
bedded in Neg50 (Richard-Allan Scientific, Kalamazoo, MI,
USA) and cut into 20-μm sections with a cryostat. For immu-
nostaining, sections were incubated overnight with the desired
primary antibody at 4 °C after blocking, and then with the
corresponding secondary antibody for 1 h at 25 °C. In the case
of double immunofluorescence staining, after a wash, the
same section was incubated overnight with another primary
antibody at 4 °C. Subsequently, it was incubated with the
corresponding secondary antibody for 1 h at 25 °C.
Omission of primary antibodies served as a negative control.
No immunostaining was detected in this group. The following
primary antibodies were used: mouse monoclonal anti-Ki67
(Cat. No. 556003, BDBioscience, San Jose, USA), goat poly-
clonal anti-doublecortin (DCX) (Cat. No. SC-8066, Santa
Cruz Biotechnology Inc., Santa Cruz, CA, USA), or goat
polyclonal anti-NeuroD (Cat. No. SC-1084, Santa Cruz) anti-
body. The secondary antibodies used were as follows: Alexa
Fluor 488-labeled donkey anti-mouse IgG (Molecular Probes
Inc., Eugene, OR, USA) and Alexa Fluor 594-labeled donkey
anti-goat IgG antibodies (Molecular Probes Inc.).
Fluorescence was detected by using an Olympus fluorescence
microscope (IX-71; Olympus). Fluorescent images were load-
ed into theMetaMorph software program (Molecular Devices,
Downingtown, PA). Based on background fluorescence and
the size of their nucleus, NeuroD-labeled cells in the SGZ and
granule cell layer (GCL) of the hippocampal dentate gyrus
were counted by use of the MetaMorph software program in
five sections per animal, which areas corresponded to coronal
coordinates of −3.14 to −4.52 from bregma.
Statistical Analysis
The results were expressed as the means ± standard error of
the mean (SEM). Differences between two groups were eval-
uated statistically by use of the unpaired Student’s t test.
Statistical comparison among multiple groups was evaluated
by analysis of variance (ANOVA), followed by Bonferroni
test as a post hoc test. P values of less than 0.05 were consid-
ered significant.
Results
GSK-3β/β-Catenin Signaling Pathway After ME
It is known that GSK-3β is inactivated by phosphory-
lation at its Ser9 and activated by that at its Tyr216. We
first determined the time course of changes in phosphor-
ylation levels of GSK-3β at Ser9 as well as at Tyr216
in the hemispheres after surgery. The phosphorylation
level of GSK-3β at Ser9 of ME-operated rats was sig-
nificantly increased compared with that of sham-
operated rats on day 7 (Fig. 1a). In contrast, there were
no significant differences in phosphorylation level of
GSK-3β at Tyr216 between sham- and ME-operated
rats throughout the experiment (Fig. 1b). Normally, β-
catenin is phosphorylated by GSK-3β in the cytosol and
is degraded by the ubiquitin-proteasome pathway. As
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GSK-3β was inactivated by marked phosphorylation at
Ser9 on day 7 after ME, we next examined the phos-
phorylation level of β-catenin in the cytosolic fraction.
Only on day 7 after ME, the phosphorylation level of
β-catenin was decreased relative to that of sham-
operated control (Fig. 2a). It is known that GSK-3β at
Ser9 is phosphorylated by Akt [36]. Next, to examine
the upstream of phosphorylated GSK-3β, we assessed
the time course of changes in the level of phosphory-
lated Akt. Phosphorylation of Akt at its Ser473, which
activates the enzyme, after ME gradually increased as
Fig. 2 Time course of changes in the levels of phosphorylated β-catenin
after cerebral ischemia. a Time course of changes in the phosphorylation
of β-catenin and total levels of β-catenin in the sham- (sham; white bars)
and ME-operated (ME; black bars) on days 1, 3, 7, and 14 after surgery.
Bands corresponding to phosphorylated β-catenin (pβ-catenin) and total
β-catenin were scanned, and the scanned bands were normalized by total
β-catenin on the same blot. b Time course of changes in the
phosphorylation of Akt and total levels of Akt in the sham- (sham) and
ME-operated (ME) on days 1, 3, 7, and 14 after surgery. Bands
corresponding to phosphorylated Akt (pAkt) and total Akt were
scanned, and the scanned bands of pAkt were normalized by total Akt
on the same blot. Results are expressed as the mean ratio of the ME group
to the non-operated (naïve) group ± SEM (n = 5 each). *Significant
difference from the sham-operated group (p < 0.05)
Fig. 1 Time course of changes in the levels of phosphorylated GSK-3β
after cerebral ischemia. a Time course of changes in the phosphorylation
of GSK-3β at its Ser9 and total levels of GSK-3β in the sham- (sham;
white bars) and ME-operated (ME; black bars) on days 1, 3, 7, and 14
after surgery. Bands corresponding to phosphorylated GSK-3β at Ser9
(pGSK-3β [Ser9]) and total GSK-3β (GSK-3β) were scanned, and the
scanned bands were normalized by total GSK-3β on the same blot. b
Time course of changes in the phosphorylation of GSK-3β at its Tyr216
and total levels of GSK-3β in the sham- (sham) and ME-operated (ME)
on days 1, 3, 7, and 14 after surgery. Bands corresponding to
phosphorylated GSK-3β at its Ser9 (pGSK-3β (Ser9)) and total GSK-
3β (GSK-3β) were scanned, and the scanned bands were normalized by
total GSK-3β on the same blot. Results are expressed as the mean ratio of
the ME group to the non-operated (naïve) group ± SEM (n = 5 each).
*Significant difference from the sham-operated group (p < 0.05)
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compared with that of sham-operated rats up to day 7
(Fig. 2b). The increased phosphorylation of Akt at
Ser473 remained on day 14 after ME. The greatest in-
crease was seen on day 7 after ME (Fig. 2b).
Cell Proliferation and Differentiation After ME
The GSK-3β/β-catenin signaling pathway is associated
with the expression of NeuroD, which plays an important
role in neural differentiation. We therefore determined cell
proliferation and differentiation in the hippocampal den-
tate gyrus on day 7 after ME at the same time period
during which the phosphorylation of GSK-3β at Ser9
was significantly increased. We initially performed immu-
nostaining using Ki67 antibody, a marker of proliferating
cells, to confirm cell proliferation after ME. Ki67-positive
cells were detected in the hippocampal dentate gyrus, and
their number was increased in the ipsilateral dentate gyrus
(Fig. 3e, f) compared with that in the sham-operated rats
(Fig. 3a, b). Next, to determine whether the proliferating
cells differentiated into neurons, we examined the expres-
sion of a neural marker in these Ki67-positive cells. Ki67-
positive cells expressed DCX, a marker for immature neu-
rons, on day 7 after ME (Fig. 3c–i). Furthermore, the
expression of NeuroD, which plays an important role in
neural differentiation, was enhanced in the ipsilateral den-
tate gyrus after ME (Fig. 4d–f) compared with that in the
sham-operated rats (Fig. 4a–c). This increase in the num-
ber of NeuroD-positive cells was detected in the ipsilater-
a l denta te gyrus on day 7 af ter ME (Fig. 4g) .
Immunoblotting analysis also showed that the level of
NeuroD after ME was significantly increased compared
with that of sham-operated rats (Fig. 4h–i).
We next assessed the effect of wortmannin, an inhibitor of
PI3-K, on the phosphorylation of Akt and GSK-3β on day 7
after ME. The increased phosphorylation of Akt after ME was
almost completely suppressed by the treatment with
wortmannin (Fig. 5a). Also, the marked increase in phosphor-
ylation of GSK-3β on its Ser9 after ME was attenuated by the
wortmannin treatment (Fig. 5b). In contrast, phosphorylation
of GSK-3β on Tyr216 was not affected by ME regardless of
treatment or not with this inhibitor (Fig. 5c). Furthermore, the
decreased phosphorylation of β-catenin was attenuated by
treatment with wortmannin (Fig. 5d). To determine whether
the Akt/GSK-3β signaling pathway contributed to
neurogenesis via the expression of NeuroD, we next examined
the effect of wortmannin on the number of NeuroD-positive
cells in the hippocampal dentate gyrus on day 7 after ME. The
number of NeuroD-positive cells in ME rats treated with
wortmannin was lower than that of those in untreated ME rats
(Fig. 6).
Possibility of Involvement of IGF-1 and BDNF in GSK-3β
Signaling After ME
We next hypothesized that some growth factors are involved
in the altered Akt-GSK-3β-β-catenin signaling pathway after
ME. Therefore, we investigated the expression of IGF-1 and
BDNF on day 7 after the operation. The expression levels of
IGF-1 (Fig. 7a) and BDNF (Fig. 7b) in ME-operated rats were
significantly decreased compared with those of the sham-
operated rats (Fig. 7).
Discussion
In previous studies, we demonstrated that ME increased pro-
liferation of cells that expressed nestin, a neural progenitor
marker, and DCX, a microtubule-associated protein found in
migrating immature neurons. Furthermore, a few proliferated
Fig. 3 Enhancement of cell
proliferation and differentiation in
the hippocampal dentate gyrus on
day 7 after cerebral ischemia. a, b
Cells in the dentate gyrus were
stained with Hoechst33342
(Hoechst). b, fKi67-positive cells
in the SGZ of the ipsilateral
dentate gyrus of sham-operated
(b) and ME (f) rats. c, g Ki67-
positive cells (green) expressed a
marker for immature neuron
(DCX; red). d, h Images of
double staining (merge) with
Ki67 (green, b, f) and DCX (red,
c, g). i Image of double staining
with Ki67 and DCX in BH^ is
enlarged. Scale bar, 200 and
50 μm (in enlargement)
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cells expressed MAP2, a neural marker, whereas GFAP was
not expressed on day 28 [37]. These data imply that ME pro-
moted cell proliferation, migration, and differentiation into
neurons. However, the maximum increase in the number of
proliferating cells on day 7 after ME decreased with time [37,
38]. We have also demonstrated a series of behavioral tests,
including motor, sensory, reflex, and balance tests, on days 1,
7, 14, 21, and 28 after ME according to the modified neuro-
logical severity scores (mNSS) [29]. There was a significant
reduction in the score of ME rats. Furthermore, we performed
the sucrose preference test (SPT) and forced-swimming test
(FST) as measures of post-stroke depression (PSD)-like be-
havior [29]. In that study, the sucrose preference of ME rats
decreased at 7 days after surgery, and this decrease was
sustained at least until day 28. As a decrease in sucrose con-
sumption indicates a state of anhedonia, a core symptom of
depression, we suggested that our results could be used to
estimate mood disturbance of rats after ME. Furthermore,
the immobility time in the FST was prolonged in ME rats
[29]. These results suggested that ME-induced cerebral ische-
mia affected behaviors associated with depression. On the
basis of our previous studies, the primary objective of the
present study was to determine the intracellular signaling, in-
cluding GSK pathways, in the initial stages of cerebral
ischemia-induced neurogenesis for a further understanding
of the pathophysiology of stroke, correlation between neuro-
logical dysfunction and ischemia-induced neurogenesis, and
the development of new therapeutic targets.
GSK-3β phosphorylates many substrates and is involved
in various cellular processes. Of these, β-catenin is phosphor-
ylated byGSK-3β, leading to degradation of the former by the
ubiquitin-proteasome system, whereas non-phosphorylated
β-catenin in the cytosol is translocated to the nucleus, where
it acts as transcriptional factor to promote the expression of
NeuroD [9]. In the present study, the inactivation of GSK-3β
induced by phosphorylation at its Ser9 was significantly en-
hanced in particular on day 7 after ME. In contrast, there were
no changes in the phosphorylation of GSK-3β at Tyr216 com-
pared with that of in the sham-operated group throughout the
experiment. Changes in activity of GSK-3β depend on the
region of the injury and the severity of brain ischemia models
[39, 40]. Although neurogenesis is regulated by various sig-
naling pathways, the ability of GSK-3β to play an important
role in adult neurogenesis has been observed [41, 42]. For
example, lithium, a GSK-3β inhibitor, increases adult
neurogenesis in rodents [43]. Akt is known to phosphorylate
GSK-3β at Ser 9 [36]. Thus, inactivation of GSK-3β by phos-
phorylation at its Ser9 after ME might be associated with Akt
Fig. 4 Increase in the number of NeuroD-positive cells after cerebral
ischemia. Images of double staining (merge, c, f) with Hoechst 33342
(Hoechst, a, d) and for NeuroD (red, b, e) in the ipsilateral hippocampal
dentate gyrus on day 7 after sham (a–c) and cerebral ischemia (d–f). Scale
bar, 200 μm. g The number of NeuroD-positive cells in the ipsilateral
SGZ of sham-operated (Sham7) and ME-operated (ME7) rats on day 7
after surgery. Values for NeuroD-positive cells are represented as the
mean ± SEM. *Significant difference from the sham-operated group
(p < 0.05). h, i Immunoblotting analysis for the level of NeuroD protein
in the sham- (Sham7) andME-operated (ME7) rats on day 7 after surgery.
Bands corresponding to NeuroD and β-actin were scanned, and the
scanned bands were normalized by β-actin on the same blot (h, i).
Results are expressed as the mean ratio of the ME group to the sham-
operated group ± SEM (n = 5 each). *Significant difference from the
sham-operated group (p < 0.05)
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activation. Indeed, we demonstrated that Akt phosphorylation
was enhanced on day 7 after ME. These results raise the pos-
sibility that Akt/GSK-3β/β-catenin signalingmight have been
enhanced after ME and contributed to neurogenesis via the
expression of NeuroD.
To further determine the possible involvement of Akt-
GSK-3β signaling pathways in ischemia-induced
neurogenesis, we examined the effect of wortmannin, an in-
hibitor of the PI3-K/Akt pathway, on phosphorylation levels
of Akt and GSK-3β, as well as on the expression of NeuroD.
Treatment with wortmannin decreased the levels of phosphor-
ylated of Akt and GSK-3β on its Ser9 without causing any
change in phosphorylation on Tyr216 on day 7 after ME. The
number of NeuroD-positive cells treated with wortmannin
tended to be lower than that in the untreated control group.
Our results suggest that this PI3-K-dependent Akt/GSK-3β/
β-catenin signaling pathway was, at least in part, associated
with the expression of NeuroD after severe cerebral ischemia.
In accordance with our previous studies [37, 44], cerebral
ischemia-induced cell proliferation was enhanced, and DCX,
an immature neural marker, was expressed in the proliferating
cells in the present study. These responses were accompanied
by an increased number of NeuroD-positive cells in the ipsi-
lateral dentate gyrus. Neurod1-null mice die perinatally from
neonatal diabetes [45]. In addition, NeuroD-deficient neurons
also die prematurely in the early stage of neurogenesis [46],
suggesting that NeuroD is indispensable for neuronal differ-
entiation and maturation at the developmental stage and for
Fig. 5 Effects of wortmannin on GSK-3β signaling. Effects of
wortmannin on the phosphorylation of Akt (a), GSK-3β (Ser9; b),
GSK-3β (Tyr216; c), and β-catenin (d) on day 7. Proteins from sham-
operated (Sham7) and ME rats on day 7 without (ME7) or with
wortmannin (ME7 + Wort) were subjected to immunoblotting with anti-
phospho-Akt (pAkt), anti-phospho-GSK-3β at Ser9 (pGSK-3β [Ser9]),
anti-phospho-GSK-3β at Tyr216 (pGSK-3β [Tyr216]), or anti-phospho-
β-catenin (pβ-catenin) antibody. The blots were then stripped and re-
probed with anti-Akt, GSK-3β, or β-catenin antibody. Bands corre-
sponding to phosphorylated forms and non-phosphorylated forms were
scanned, and the scanned bands of phosphorylated proteins were normal-
ized by non-phosphorylated proteins on the same blot. Results are
expressed as the mean ratio of the ME group to the sham-operated
group ± SEM (n = 5 each). *Significant difference from the sham-
operated group (p < 0.05). #Significant difference from the ME-
operated group (p < 0.05)
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maintenance of progenitor cells. This view is consistent with
the finding that conditional deletion of NeuroD1 leads to a
decrease in the number of progenitors/immature neurons in
the adult brain [10].
As described above, neurogenesis is regulated by var-
ious factors such as the environment, growth factors, and
neurotransmitters [47–49]. Among considerable factors as
important regulators of neurogenesis, it is well known that
some growth factors are involved in adult neurogenesis.
IGF-1 plays a crucial role in neurogenesis [50, 51]. The
stimulation of cells by IGF-1 causes the inactivation of
GSK-3β through a PI3-K-dependent mechanism [52].
Furthermore, the blockade of ischemia-induced GSK-3β
inactivation via the inhibition of the PI3-K or of IGF-1
receptor reverses the phosphorylation of GSK-3β at its
serine 9 residue [53]. Thus, IGF-1/GSK-3β signaling
might be cri t ical for ischemia-induced neuronal
hyperproliferation in the hippocampal dentate gyrus re-
gion. These findings imply that the IGF-1-dependent
PI3-K/Akt/GSK-3β/β-catenin signaling pathway is close-
ly related to ischemia-induced neurogenesis. Interestingly,
we demonstrated significant decreases in the level of IGF-
1 on day 7 after cerebral ischemia, when the phosphory-
lation state of GSK-3β was at its maximum. It was also
shown earlier that BDNF expression and neurogenesis in
the hippocampus of depressive model animals are de-
creased [54, 55]. Moreover, infusion of BDNF into the
hippocampus of these animals improves their depressive
behavior and increases neurogenesis [56, 57]. Therefore,
changes in the expression of BDNF are important as un-
derlying determinants of depressive behavior and adult
neurogenesis. We demonstrated previously that intrave-
nous injection of NPCs on day 7 after ME improves
post-stroke depression-like behaviors on day 28 after
ME [29]. Also, the injection of NPCs inhibits the decrease
in the level of BDNF after ME [29]. Interestingly, injected
NPCs are maintained in an undifferentiated condition and
Fig. 6 Decrease in the number of
NeuroD-positive cells by
treatment with wortmannin. a–f
Images of double staining (merge,
c, f) with Hoechst 33342
(Hoechst, a, d) and NeuroD (red,
b, e) in the ipsilateral
hippocampal dentate gyrus on
day 7 after ME with wortmannin
treatment (d, e, f). Scale bar,
200 μm. g Number of NeuroD-
positive cells in the ipsilateral
SGZ on day 7 after ME without
(ME7) or with wortmannin
(ME7 + Wort). Values for
NeuroD-positive cells are
presented as the mean ± SEM
(n = 6 each). *Significant
difference from the ME-operated
group (p < 0.05)
Fig. 7 Changes in the levels of IGF-1 and BDNF after cerebral ischemia.
Immunoblotting analysis for the level of IGF-1 (a) or BDNF (b) protein
in the sham- (Sham7) and ME-operated (ME7) on day 7 after surgery.
Bands corresponding to IGF-1 and BDNFwere scanned, and the scanned
bands were normalized byβ-actin on the same blot. Results are expressed
as the mean ratio of the ME group to the sham-operated group ± SEM
(n = 5 each). *Significant difference from the sham-operated group
(p < 0.05)
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might function as cells producing neurotrophic factors
[29]. In the present study, the level of BDNF was rather
decreased on day 7 after ME, when endogenous prolifer-
ation was at its maximum. It is well recognized that
BDNF is involved in leaning and memory function, neu-
roprotection and/or repair, as well as in also neurite out-
growth. Although increased levels of BDNF after cerebral
ischemia have been reported [58], it has been also dem-
onstrated that the expression level of BDNF, as well as
IGF, protein is significantly decreased compared with that
in the appropriate control group in well-established stroke
models such as the MCAO model [59–61]. Our results in
the current study and previous study [29] are consistent
with the latter findings. The decrease in the protein level
of BDNF appears to be associated with injured brain re-
gions, such as between ischemic penumbra and core, and
the severity of ischemic models. Although cellular sources
of IGF-1 and BDNF are still not clear, our results imply
that the levels of IGF-1 and BDNF in NPCs per se and/or
their focal concentrations around the NPCs might be crit-
ical for improving ischemic injur ies . Al though
neurogenesis is coordinately regulated by several factors,
our findings imply that an IGF-1- and/or BDNF-
independent PI3-K/Akt/GSK-3β pathway was enhanced
by cerebral ischemia. In this sense, it is interesting that
ethosuximide, an anticonvulsant drug, induces NSC pro-
liferation and differentiation associated with increased
phosphorylation of PI3-K, Akt, and GSK-3β and de-
creased phosphorylation of β-catenin, suggesting that
the PI3-K/Akt/GSK-3β pathway had been enhanced [62].
In conclusion, as evidence of one of the endogenous
regeneration abilities after cerebral ischemia, the number
of NeuroD-positive cells was increased compared with
that in the sham group on day 7 after surgery. It is
noteworthy that the PI3-K/Akt-dependent GSK-3β sig-
naling pathway was involved in the expression of
NeuroD, which underlies cerebral ischemia-induced
neurogenesis. Furthermore, IGF-1 and BDNF might not
be essential for activation of this pathway after severe
cerebral ischemia. Although it remains to be determined
what factors activated this pathway, the present study
provides evidence that PI3-K/Akt-dependent GSK-3β
signaling was involved in neurogenesis after ME.
Whereas future studies will be needed to determine
changes in GSK-3β phosphorylation of specific areas
in the ipsilateral hemisphere, it is possible that enhance-
ment of GSK-3β phosphorylation was not maintained
due to the severe ischemic condition and that repair
mechanisms after ME might not be exerted completely.
As ischemia-induced neurogenesis did not repair the se-
vere cell and tissue damages, selective and focal en-
hancement of GSK-3β/β-catenin pathways might be
needed as therapy for ischemic injuries.
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